HOLD Alapkezelo Zrt. discloses 8.1% MediWound (MDWD) ownership in amended filing

Rhea-AI Filing Summary

HOLD Alapkezelo Zrt., a Hungarian investment fund management company, filed an amended ownership report showing a significant stake in MediWound Ltd. common shares.

The firm is deemed to beneficially own 1,039,954 common shares, representing approximately 8.1% of MediWound’s outstanding common stock, based on 12,835,186 shares outstanding as of January 16, 2026. HOLD Alapkezelo Zrt. has sole voting and sole dispositive power over all of these shares and no shared voting or dispositive power.

The filer certifies that the securities were not acquired and are not held for the purpose of changing or influencing control of MediWound, and are not held in connection with any control-related transaction.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

MediWound Ltd.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

M68830104

(CUSIP Number)

02/13/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. M68830104

1

Names of Reporting Persons

HOLD Alapkezelo Zrt.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

HUNGARY

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,039,954.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,039,954.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,039,954.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.1 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Hungarian investment fund management company without SEC registration.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MediWound Ltd.
(b)	Address of issuer's principal executive offices: 42 HAYARKON STREET, 42 HAYARKON STREET, YAVNE, ISRAEL, 8122745.
Item 2.
(a)	Name of person filing: HOLD Alapkezelo Zrt. (HUNGARY)
(b)	Address or principal business office or, if none, residence: H-1123 Budapest, Alkotas u. 50., Hungary
(c)	Citizenship: Hungary
(d)	Title of class of securities: Common Shares
(e)	CUSIP No.: M68830104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The percentage set forth in Row 13 of the cover page for each Reporting Person is based upon 12,835,186 shares of the Issuers common stock outstanding as of January 16, 2026, in accordance with Issuer's 6-K filed on January 15, 2026. HOLD Alapkezelo Zrt. have been deemed to have the beneficial ownership of 1,039,954 shares of common stock representing the beneficial ownership of approximately 8.1% of the common stocks.
(b)	Percent of class: HOLD Alapkezelo Zrt: 8.1%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: HOLD Alapkezelo Zrt.: 1,039,954 shares of Common Stock
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: Sole power to dispose or to direct the disposition of: HOLD Alapkezelo Zrt.: 1,039,954 shares of Common Stock
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

HOLD Alapkezelo Zrt.

Signature:	Daniel Moricz
Name/Title:	Chief Investment Officer, Partner
Date:	02/13/2026

Exhibit Information

https://ir.mediwound.com/static-files/3fa3acce-5080-4920-bff3-ac8e6c40b189

FAQ

What ownership stake in MediWound Ltd. (MDWD) does HOLD Alapkezelo Zrt. report?

HOLD Alapkezelo Zrt. reports beneficial ownership of 1,039,954 MediWound common shares. This represents approximately 8.1% of MediWound’s common stock, based on 12,835,186 shares outstanding as of January 16, 2026, as referenced in MediWound’s Form 6-K.

How many MediWound (MDWD) shares are outstanding for the 8.1% figure?

The 8.1% ownership is calculated using 12,835,186 MediWound common shares outstanding. This outstanding share count is as of January 16, 2026, according to the company’s Form 6-K, and is used as the base for HOLD Alapkezelo Zrt.’s reported percentage.

Does HOLD Alapkezelo Zrt. have sole or shared voting power over MediWound (MDWD) shares?

HOLD Alapkezelo Zrt. has sole voting power over all 1,039,954 MediWound shares it reports. The filing states zero shared voting power, indicating the firm alone can vote or direct the vote for these shares under current arrangements.

What dispositive power does HOLD Alapkezelo Zrt. report over MediWound (MDWD) shares?

The firm reports sole dispositive power over 1,039,954 MediWound common shares. It has no shared dispositive power, meaning HOLD Alapkezelo Zrt. alone may decide whether and how to dispose of these shares, according to the ownership disclosure.

Is HOLD Alapkezelo Zrt. seeking to influence control of MediWound (MDWD)?

The filer certifies the MediWound shares were not acquired to change or influence control. It also states the holdings are not in connection with any transaction designed to affect control, other than activities solely related to a nomination under the specified proxy rule.

What type of entity is HOLD Alapkezelo Zrt. in the MediWound (MDWD) filing?

HOLD Alapkezelo Zrt. is described as a Hungarian investment fund management company. The filing notes that it operates without SEC registration and is organized in Hungary, with its principal business office located in Budapest at Alkotas u. 50.